AusBiotech

Today AusBiotech and MTPConnect have released a Discussion Paper on critical life science growth issues ahead of their upcoming National Biotech and Medtech Development and Commercialisation Summit, on 19 November 2024 in Canberra.   Australia's life sciences sector is an essential part of Australia’s economy, supporting high-paying and skilled jobs, manufacturing exports, and underpinning the health and wellbeing of Australians. It is rightly recognised by the Australian Government as a critical sector that is essential for Australia’s future. Yet while we are in the top ten globally for research, we slip down to 30th for the translation and commercialisation of that research. The upcoming Summit will see AusBiotech and MTPConnect gather some of the country’s most senior leaders from a cross-section of the biotech and medtech sector to tackle these issues. AusBiotech CEO Rebekah Cassidy said Australia is already recognised as a global incubator for outstanding medical research. How we build upon that to also be recognised for our capacity to translate, develop and commercialise those ideas to build more great Australian companies is the opportunity we need to harness. “The time is now for Australia to realise the potential of its growing biotech and medtech sector. By advancing our life sciences industry, bringing innovations to market quicker, ensuring we have the Australian based skills and capability we need to succeed – we can play a greater role in securing the health of Australians and our national competitive advantage," Rebekah said.   The joint discussion paper launched today unpacks Australian and global policy contexts, stubborn industry challenges, and barriers to achieving robust “Development and Commercialisation” outcomes. Add your voice to the discussion: The Summit is one part of the conversation, your insights are crucial to ensuring the discussions and any outputs reflect the diverse perspectives of the industry. We invite you to complete the survey to share your views: https://lnkd.in/gEGpQHb9 Read the Discussion Paper: https://lnkd.in/gX6mQSwU

AusBiotech, Australia’s leading national industry association representing more than 3000 members across the life sciences sector and BioMelbourne Network, Victoria’s leading industry association for organisations engaged in biotechnology, medical technology, and health innovation, have announced the signing of a MOU to promote stronger collaboration between both organisations. This week's signing marks a significant milestone as our organisations work to support the state and national growth agenda for the life sciences ecosystem. “I couldn’t be more delighted to formalise AusBiotech’s relationship with BioMelbourne Network here at our AusBiotech 2024 Conference. Both of our organisations have a proud history of advocating on behalf of our members and share common goals when it comes to furthering the opportunities for life sciences sector growth, “said Rebekah Cassidy, AusBiotech CEO.

AusBiotech and Life Sciences Queensland Ltd (LSQ) have signed a Memorandum of Understanding (MOU) to strengthen collaboration and drive Australia’s life sciences industry forward.   AusBiotech CEO Rebekah Cassidy and LSQ Acting CEO Dr Ryan Parlett signed the MOU at #AusBio24.   This agreement with LSQ represents a strategic commitment to support the growth and resilience of Australia’s life sciences ecosystem. The MOU outlines an ambitious framework for cooperation, emphasising member engagement, knowledge exchange, and a unified approach to sector advocacy.    "By working together, we can leverage our combined strengths to advance research, support our members, and ultimately improve health outcomes for all Australians. Both of our organisations recognise the growing necessity to retain and nurture homegrown research, biotechnology, and medtech to protect against the evolving challenges of our global environment," said Rebekah Cassidy, AusBiotech CEO.

Day One of #AusBio24 was a strong start!    Hear our CEO, Rebekah Cassidy, talk about the value of gathering Australia’s #lifesciences industry for connection, collaboration, and knowledge sharing. The lineup was inspiring: We heard from pioneers like Dr Daniel Timms, Founder & Chief Technical Officer of BiVACOR, and his remarkable journey toward developing the first artificial heart. Discussions spanned Australia's evolving manufacturing landscape and emerging frontiers like quantum computing. The story of innovation and impact going hand in hand in this vibrant industry is a strong theme. Thanks to the Victorian Government for being our Host State Partner. Global Victoria, Invest Victoria, Department of Jobs, Skills, Industry and Regions

We were honoured to have the Hon Mark Butler MP for Health and Aged Card address Australia’s life sciences industry on Day One of the biggest week in biotech: the AusBiotech 2024 Conference. We are grateful for his strong commitment and support for AusBiotech, our members, and our industry. "But I also want to make clear my desire, the government’s desire, to continue to work with AusBiotech and its industry members to bridge the gap between invention and realisation. "We need a whole pipeline approach – from discovery to start-up, clinical trials, manufacturing, export, access and reimbursement. Health is at the beginning and the end of that pipeline."   "And, to the people in this room—from the start-ups, the small to medium enterprises, the research institutes, multinationals, investors and manufacturers, I say, we are stronger together,” said Minister Butler. #AusBio24 Read Minister Butler’s full speech from the day. https://lnkd.in/g48pqRuc

Yesterday we felt how alive Australia’s life science sector is —thanks to the 23 presenting companies and leading investors, speakers and panellists who joined us for one of Australia's premier investment events – AusBioInvest. We are proud to be the connector between companies and capital.    We asked some of the CEOs who presented at AusBioInvest how valuable it is to connect with investors at various stages of their company’s journey.  Here’s what they had to say. Rebecca McQualter Leslie Chong Michael Baker Rebekah Cassidy Rosanne Hyland Rhenu Bhuller Karyn McIntosh Nicky Tillyer Kirsty Howell Britney Toogood Genevieve Ward Tanya Daw

Building connections across Australia’s life sciences sector has been at the heart of AusBiotech's work for over 38 years. Our CEO, Rebekah Cassidy, and Deputy CEO, Rosanne Hyland, joined health, biotech, and life sciences professionals at the Victorian Networking Reception last night. We thank the Treasurer of Victoria and Minister for Economic Growth, Tim Pallas MP, for hosting the event and telling the story of the momentum happening across Victoria’s—and Australia’s—thriving life sciences sector. It’s always great to reconnect with familiar faces and meet new ones. With only hours until #AusBiotech2024, we’re gearing up for ‘the biggest week in biotech’ – stay tuned.

Gearing up for an exciting pre-conference day at #AusBiotech2024 with three incredible sold-out site tours showcasing Australia's biotech excellence. Here's a sneak peek of what's in store:    1️⃣ La Trobe University : We'll explore the La Trobe Institute for Molecular Science (LIMS), Bio Innovation and Digital Innovation Hubs, home to over 19 companies co-located at Bundoora, and preview the future BioNTech SE mRNA facility. Experience cutting-edge research where technology meets biology.    2️⃣ Monash University Technology Precinct: A world-class innovation hub with a vibrant, connected community. Our tour will include the Monash Biomedical Discovery Institute and the Medicines Manufacturing Innovation Centre - MMIC and engage with experts pushing the boundaries of drug discovery and development as part of the Monash University Clinical Trials Centre.     3️⃣ Melbourne Parkville Precinct: One of the world’s leading biomedical precincts delivers outstanding patient care, cutting-edge research and discoveries, and training to some of the country’s brightest minds. It is home to over 40 world-class biomedical organisations. We'll visit Cell Therapies at Peter MacCallum Cancer Centre and the WEHI (Walter and Eliza Hall Institute of Medical Research) National Drug Discovery Centre, experiencing firsthand the groundbreaking work in advanced therapies and drug discovery.    These tours showcase the incredible ecosystem driving Australia's biotech innovation. A huge thank you to our hosts and all participants for making this possible! A perfect way to start the learning, connection and networking of the #AusBio24 Conference. With thanks to host state partners Global Victoria, Invest Victoria, Department of Jobs, Skills, Industry and Regions The Royal Children's Hospital, The Florey Institute, The Peter Doherty Institute for Infection and Immunity, University of Melbourne

#AusBioInvest 2024, Australia's premier biotech investment event, will bring together local and international health investors at the Park Hyatt on Tuesday, 29 October 2023, in Melbourne. This full-day conference will provide you with a rare opportunity to hear from keynote and panel investor speakers, and 23 private and public companies spanning early to late-stage development, demonstrating the potential of Australia’s life sciences. ✔️Investors - qualified investors are eligible for complimentary registration. Apply now https://lnkd.in/g7bJ5ZTc ✔️Interested delegates - Hear from our line-up of life science companies and network with CEOs, pharma executives and life science investors. A standard registration rate is available here https://lnkd.in/g2DWJfVq AusBiotech is grateful to host state partner Victoria State Government for their ongoing support. #AusBioInv24 Global Victoria, Invest Victoria, Department of Jobs, Skills, Industry and Regions

📢AusBiotech is pleased to announce that Tim Pallas MP, the Victorian Minister for Economic Growth, and the Hon. Natalie Hutchins MP, the Victorian Minister for Jobs and Industry, will both speak at Australia’s biggest week in biotech – at #AusBioInvest2024 and #AusBiotech2024.   The Victorian State Government is the Host State Partner for this year’s AusBioInvest and AusBiotech Conference in Melbourne, running from Tuesday, 29 October until Friday, 1 November.      AusBiotech CEO Rebekah Cassidy highlighted the Victorian Government's partnership and support as a vital contributor to Australia's thriving #lifesciences sector.     “One of the pre-eminent biotechnology industry conferences in the Asia-Pacific region, AusBiotech's four-day conference is Australia's largest annual biotechnology gathering. It convenes Australia’s leading life science players and continues to attract a global audience of delegates and investors,” she said.     Tim Pallas MP, Minister for Economic Growth, will officially open AusBioInvest on 29 October. The one-day AusBioInvest programme will welcome over 250 delegates representing Australia’s leading life science companies and local and global investors at the Park Hyatt, Melbourne.     The Hon. Natalie Hutchins MP, Minister for Jobs and Industry, will formally address the conference's more than 1,500 participants, including 200 international delegates from 20 countries, on 30 October at the Melbourne Convention and Exhibition Centre.      AusBiotech is grateful to Minister Pallas and Minister Hutchins for their ongoing support of Australia’s thriving science sector.    Read our full media release https://lnkd.in/e3TBWJqQ #AusBio24 #AusBioInv24 Global Victoria, Invest Victoria, Department of Jobs, Skills, Industry and Regions